Heterogeneity in Comparisons of Discontinuation of Tumor Necrosis Factor Antagonists in Rheumatoid Arthritis - A Meta-Analysis

Public Deposited
Analytics

Downloadable Content

Download PDF
Request Version for Screen Reader
Creator
  • Fisher, Anat
    • Other Affiliation: Department of Anesthesiology; Pharmacology and Therapeutics; University of British Columbia
  • Bassett, Ken
    • Other Affiliation: Department of Anesthesiology; Pharmacology and Therapeutics; University of British Columbia
  • Goel, Gautam
    • Other Affiliation: Department of Family and Community Medicine; University of Toronto
  • Stanely, Dana
    • Other Affiliation: Department of Anesthesiology; Pharmacology and Therapeutics; University of British Columbia
  • Brookhart, M. Alan
    • Affiliation: Gillings School of Global Public Health, Department of Epidemiology
  • Freeman, Hugh R.
    • Other Affiliation: Department of Medicine; University of British Columbia
  • Wright, James M.
    • Other Affiliation: Department of Anesthesiology; Pharmacology and Therapeutics; University of British Columbia
  • Dormuth, Colin R.
    • Other Affiliation: Department of Anesthesiology; Pharmacology and Therapeutics; University of British Columbia
Abstract
  • We did a systematic review of studies comparing discontinuation of tumor necrosis factor alpha (TNF) antagonists in rheumatoid arthritis (RA) patients, pooled hazard ratios and assessed clinical and methodological heterogeneity.
Date of publication
Keyword
DOI
Identifier
Resource type
  • Article
Rights statement
  • In Copyright
Journal title
  • PloS One
Journal volume
  • 11
Journal issue
  • 12
Page start
  • e0168005
Language
  • English
ISSN
  • 1932-6203

Relations

Parents:

This work has no parents.

In Collection:

Items

Thumbnail Title Date Uploaded Visibility Actions
file details PubMedCentral-PMC5145210.pdf 2016 Public Download